ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 182 filers reported holding ARCUS BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,293 | +2.4% | 72,018 | +15.8% | 0.06% | +10.9% |
| Q2 2023 | $1,263 | -40.3% | 62,188 | -46.4% | 0.06% | -45.0% |
| Q1 2023 | $2,117 | +664.3% | 116,089 | +767.4% | 0.10% | +566.7% |
| Q4 2022 | $277 | -100.0% | 13,383 | -63.1% | 0.02% | -73.7% |
| Q3 2022 | $949,000 | +65.0% | 36,293 | +60.0% | 0.06% | +32.6% |
| Q2 2022 | $575,000 | +63.4% | 22,690 | -10.6% | 0.04% | -70.9% |
| Q1 2020 | $352,000 | -65.8% | 25,378 | -75.1% | 0.15% | -51.8% |
| Q4 2019 | $1,029,000 | +619.6% | 101,846 | +549.9% | 0.31% | +479.2% |
| Q3 2019 | $143,000 | – | 15,670 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |